The effect of tissue plasminogen activator and reperfusion on infarct growth between baseline diffusion-weighted imaging and day 90 T2 imaging was assessed , along with good neurological outcome ( 8 point reduction or reaching 0-1 at 90 days on National Institutes of Health Stroke Scale ) and functional outcome ( modified Rankin scale ) .